219 related articles for article (PubMed ID: 24199868)
1. Single point mutations induce a switch in the molecular mechanism of the aggregation of the Alzheimer's disease associated Aβ42 peptide.
Bolognesi B; Cohen SI; Aran Terol P; Esbjörner EK; Giorgetti S; Mossuto MF; Natalello A; Brorsson AC; Knowles TP; Dobson CM; Luheshi LM
ACS Chem Biol; 2014 Feb; 9(2):378-82. PubMed ID: 24199868
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Nucleated Conformational Conversion of Aβ42.
Fu Z; Aucoin D; Davis J; Van Nostrand WE; Smith SO
Biochemistry; 2015 Jul; 54(27):4197-207. PubMed ID: 26069943
[TBL] [Abstract][Full Text] [Related]
3. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide.
Kim W; Hecht MH
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15824-9. PubMed ID: 17038501
[TBL] [Abstract][Full Text] [Related]
4. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
Poduslo JF; Howell KG
J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
[TBL] [Abstract][Full Text] [Related]
5. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
Gu L; Tran J; Jiang L; Guo Z
J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
[TBL] [Abstract][Full Text] [Related]
6. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
Xu L; Chen Y; Wang X
Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of Inter-Molecular Interactions Between Single Aβ
Feng L; Watanabe H; Molino P; Wallace GG; Phung SL; Uchihashi T; Higgins MJ
J Mol Biol; 2019 Jul; 431(15):2687-2699. PubMed ID: 31075274
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
9. Different effects of Alzheimer's peptide Aβ(1-40) oligomers and fibrils on supported lipid membranes.
Canale C; Seghezza S; Vilasi S; Carrotta R; Bulone D; Diaspro A; San Biagio PL; Dante S
Biophys Chem; 2013 Dec; 182():23-9. PubMed ID: 23998637
[TBL] [Abstract][Full Text] [Related]
10. The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-β Peptide.
Selivanova OM; Surin AK; Marchenkov VV; Dzhus UF; Grigorashvili EI; Suvorina MY; Glyakina AV; Dovidchenko NV; Galzitskaya OV
J Alzheimers Dis; 2016 Sep; 54(2):821-30. PubMed ID: 27567850
[TBL] [Abstract][Full Text] [Related]
11. Direct electrochemical and AFM detection of amyloid-β peptide aggregation on basal plane HOPG.
Lopes P; Xu M; Zhang M; Zhou T; Yang Y; Wang C; Ferapontova EE
Nanoscale; 2014 Jul; 6(14):7853-7. PubMed ID: 24934601
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation at Ser
Hu ZW; Ma MR; Chen YX; Zhao YF; Qiang W; Li YM
J Biol Chem; 2017 Feb; 292(7):2611-2623. PubMed ID: 28031462
[TBL] [Abstract][Full Text] [Related]
13. Effect of the Interaction of the amyloid β (1-42) peptide with short single-stranded synthetic nucleotide sequences: morphological characterization of the inhibition of fibrils formation and fibrils disassembly.
Abraham JN; Kedracki D; Prado E; Gourmel C; Maroni P; Nardin C
Biomacromolecules; 2014 Sep; 15(9):3253-8. PubMed ID: 25093956
[TBL] [Abstract][Full Text] [Related]
14. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
[TBL] [Abstract][Full Text] [Related]
15. Abeta42, presenilins, and Alzheimer's disease.
Iwatsubo T
Neurobiol Aging; 1998; 19(1 Suppl):S11-3. PubMed ID: 9562460
[TBL] [Abstract][Full Text] [Related]
16. Interaction between Alzheimer's Abeta1-42 peptide and DNA detected by surface plasmon resonance.
Barrantes A; Rejas MT; Benítez MJ; Jiménez JS
J Alzheimers Dis; 2007 Dec; 12(4):345-55. PubMed ID: 18198421
[TBL] [Abstract][Full Text] [Related]
17. On the role of sidechain size and charge in the aggregation of A
Yang X; Meisl G; Frohm B; Thulin E; Knowles TPJ; Linse S
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5849-E5858. PubMed ID: 29895690
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease.
Iijima K; Liu HP; Chiang AS; Hearn SA; Konsolaki M; Zhong Y
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6623-8. PubMed ID: 15069204
[TBL] [Abstract][Full Text] [Related]
20. Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation.
Jeong JS; Ansaloni A; Mezzenga R; Lashuel HA; Dietler G
J Mol Biol; 2013 May; 425(10):1765-81. PubMed ID: 23415897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
